Home > Healthcare > Medical Devices > Diagnostic Devices > Self-monitoring Blood Glucose Devices Market

Self-monitoring Blood Glucose Devices Market Share

Report ID: GMI2743
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Self-monitoring Blood Glucose Devices Market Share

The self-monitoring blood glucose devices sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Self-monitoring Blood Glucose Devices Market Companies

Some of the eminent market participants operating in the self-monitoring blood glucose devices industry include:

Abbott Laboratories
AgaMatrix
All Medicus Co., Ltd.
Arkray, Inc.
Ascensia Diabetes Care Holdings AG
B. Braun Melsungen AG
Bionime Corporation
DarioHealth Corp.
Dexcom, Inc.
Essenlife Bioscience, Inc.
F. Hoffmann-La Roche Ltd.
LifeScan Inc.
Medtronic plc
Nova Biomedical, Inc.
Sinocare Inc.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global self-monitoring blood glucose devices delivery industry was valued at USD 10 billion in 2023 and is anticipated to register 11.6% CAGR between 2024 and 2032, driven by government initiatives for increasing awareness among people.

The market share from the consumables segment accounted USD 6.1 billion in 2023, owing to the increasing awareness of the importance of regular blood glucose monitoring and ongoing technological advancements.

North America self-monitoring blood glucose devices market was valued at USD 3.8 billion in 2023, owing to the high prevalence of diabetes and increasing technological advancements.

Abbott Laboratories, AgaMatrix, All Medicus Co., Ltd., Arkray, Inc., Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, DarioHealth Corp., and Dexcom, Inc.